Clinical Trial

THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation

Study acronym: THRIVE
Recruiting
View on ClinicalTrials.gov →
Summary
The study's purpose is to evaluate whether creatine supplementation can help breast cancer survivors respond quicker to exercise by improving strength, endurance, and body composition. We are seeking to compare information collected from healthy woman of the same age who have never had breast cancer to those participants who have had breast cancer and undergone chemotherapy treatment.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2024-04-29; most recent amendment 2025-12-17.
Status change: Not Yet Recruiting → Recruiting 2024-08-07
Trial Details
NCT Number NCT06395506
Lead Sponsor The University of Texas Medical Branch, Galveston
Collaborators: ThriveWell Cancer Foundation
Conditions Breast Cancer, Breast Cancer Female, Muscle Weakness
Enrollment 60 participants
Start Date 2024-10-29
Primary Completion 2028-05-31 (estimated)
Study Completion 2028-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-24